Literature DB >> 30207245

Mesenchymal Stromal Cells and Natural Killer Cells: A Complex Story of Love and Hate.

Mehdi Najar1,2, Mohammad Fayyad-Kazan3, Makram Merimi3, Arsène Burny3, Dominique Bron3, Hussein Fayyad-Kazan4, Nathalie Meuleman5, Laurence Lagneaux6.   

Abstract

Mesenchymal stromal cells (MSCs), characterized by both multidifferentiation potential and potent immunomodulatory capacity, represent a promising, safe and powerful cell based-therapy for repairing tissue damage and/or treating diseases associated with aberrant immune responses. Natural killer (NK) cells are granular lymphocytes of the innate immune system that function alone or in combination with other immune cells to combat both tumors and virally infected cells. After their infusion, MSCs are guided by host inflammatory elements and can interact with different immune cells, particularly those of the innate immune system. Although some breakthroughs have been achieved in understanding these interactions, much remains to be determined. In this review, we discuss the complex interactions between NK cells and MSCs, particularly the importance of improving the therapeutic value of MSCs. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Mesenchymal stromal cells; cellular cytotoxicity; cytokines; immunomodulation; natural killer cells; natural killer receptors.

Mesh:

Substances:

Year:  2019        PMID: 30207245     DOI: 10.2174/1574888X13666180912125736

Source DB:  PubMed          Journal:  Curr Stem Cell Res Ther        ISSN: 1574-888X            Impact factor:   3.828


  3 in total

Review 1.  Mesenchymal Stem Cells and Their Small Extracellular Vesicles as Crucial Immunological Efficacy for Hepatic Diseases.

Authors:  Yuting Tang; Peipei Wu; Linli Li; Wenrong Xu; Jiajia Jiang
Journal:  Front Immunol       Date:  2022-05-06       Impact factor: 8.786

Review 2.  The Role of Regulatory Myeloid Cell Therapy in Renal Allograft Rejection.

Authors:  Jingming Zhuang; Jiangang Hou
Journal:  Front Immunol       Date:  2021-02-24       Impact factor: 7.561

Review 3.  Mesenchymal stromal cell therapies: immunomodulatory properties and clinical progress.

Authors:  Xiaomo Wu; Ju Jiang; Zhongkai Gu; Jinyan Zhang; Yang Chen; Xiaolong Liu
Journal:  Stem Cell Res Ther       Date:  2020-08-08       Impact factor: 6.832

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.